CVC Capital revs up rare disease ambitions with $3.5B Recordati buyout
admin 2nd July 2018 Uncategorised 0Recordati has finally sealed a sale. Private equity player CVC Capital Partners agreed to drop €3.03 billion ($3.5 billion) on a 51.8% controlling stake, aiming to use its own connections to help beef up Recordati’s orphan and specialty care business.
More: CVC Capital revs up rare disease ambitions with .5B Recordati buyout
Source: fierce